the object of the invention is to stabilise pharmaceutical preparation process, which is characterised by that the preparation containing the anti oxidant.preparation of insoluble polymer material agy u00f3gy u00e1szati hozz u00e1k u00e9rintkez u00e9sbe.the polymer material is preferably polypropylene or polyethylene, and the antioxidant, 2,2 ', 2' ', 6,6', 6 '' '- hexa (1,1-dimethylethyl) - 4,4', 4 '' - [(2,4,6 - trimethyl 1,3.5 - benzotriazil) - ethylidynetriphenol triszmetil u00e9n] (irganox 1330) 1,3,5-tris [3,5 - di - (1,1-dimethylethyl) - 4 - hydroxy benzyl] - 1h, 3h, 5h - 1,3,5-triazine-2,4,6 - trione, pentaerithrityl tetrakis (3 - [(1, 3,5 - di1 - dimethyl ethyl) - 4 - hydroxy phenyl] propionate}, octadecyl-3 - (3,5 - di - (1,1-dimethylethyl) - 4-hydroxyphenyl] - propionate vagytrisz [2,4 - di - (1,1-dimethylethyl) - phenyl) phosphite or 2,2 '- di (octadecyloxy) 5.5 '- spiro bis (1,3,2 - dioxa - foszforin u00e1n). ohDen foreliggende oppfinnelsen beskriver en spesiell fremgangsmåte for å stabilisere en farmasøytisk sammensetning ved å kontakte sammensetningen med et polymermateriale omfattende en antioksidant.
